1. Fan, Wei, Cao, DuoYao, Yang, Bing, Yang, Heping, Lu, Shelly C. 2023. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis. In Journal of hepatology, 80, 443-453. doi:10.1016/j.jhep.2023.11.022. https://pubmed.ncbi.nlm.nih.gov/38086446/
2. Wang, Heran, Zhou, Yujuan, Oyang, Linda, Li, Guiyuan, Liao, Qianjin. 2019. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma. In Oncogene, 38, 5062-5075. doi:10.1038/s41388-019-0778-6. https://pubmed.ncbi.nlm.nih.gov/30886235/
3. Oyang, Linda, Ouyang, Lei, Yang, Lixia, Liao, Qianjin, Zhou, Yujuan. 2022. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis. In Cancer science, 114, 870-884. doi:10.1111/cas.15662. https://pubmed.ncbi.nlm.nih.gov/36382614/
4. Chen, Shipeng, Ma, Jinqi, Yin, Ping, Liang, Fang. 2023. The landscape of mitophagy in sepsis reveals PHB1 as an NLRP3 inflammasome inhibitor. In Frontiers in immunology, 14, 1188482. doi:10.3389/fimmu.2023.1188482. https://pubmed.ncbi.nlm.nih.gov/37359543/
5. Yang, Jie, Li, Bin, He, Qing-Yu. 2018. Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment. In Cell death & disease, 9, 580. doi:10.1038/s41419-018-0661-3. https://pubmed.ncbi.nlm.nih.gov/29784973/
智鼠故事 
